QUALCOMM (QCOM) Q4 2026 Earnings Call Transcript

Qualcomm reported fiscal Q4 non-GAAP revenue of $10.4 billion, at the high end of guidance, and EPS of $2.17 versus $3.00 a year earlier; fiscal 2026 revenue was $43.2 billion versus $44.1 billion in fiscal 2025. Automotive revenue rose 89% year over year to $2 billion, while handset revenue fell 26% to $5.1 billion. Management forecast fiscal 2027 data-center revenue of $5 billion, including more than $650 million in Q1, and expects non-handset QCT revenue to grow more than 60%; Q1 total revenue guidance is $10.4 billion to $11.2 billion. Qualcomm returned $2 billion to stockholders through $1 billion of buybacks and $1 billion of dividends, while flagging handset-market weakness and gross-margin dilution from custom silicon.

Analysis

Diversification improves durability, not necessarily earnings quality. The market may capitalize data-center sales at a lower multiple than handset/licensing revenue if custom silicon carries lower gross margins and requires continued investment. The key test is whether operating leverage—not just shipments—emerges as the business scales. With two hyperscalers accounting for most of the initial ramp, customer concentration and launch timing matter more than the headline pipeline; Amazon’s warrant arrangement also makes deal economics worth monitoring rather than assuming conventional semiconductor margins.

Horizon: The near-term setup is constructive, but the next 1–3 months hinge on Q1 data-center shipments and whether Android demand is genuine rather than inventory or price-increase pull-forward. In 6–18 months, automotive content growth and network infrastructure wins could broaden revenue, but automotive design wins monetize over long vehicle cycles; the 2027 network deployment is not an immediate earnings driver. Optical suppliers Lumentum and Corning could benefit at the margin, though Qualcomm disclosed no revenue contribution sufficient to underwrite either stock.

The contrarian risk is treating rapid non-handset growth as a clean offset to handset erosion: low-base growth and mix dilution can lift sales while restraining gross profit. Licensing renewals reduce near-term contract uncertainty, but do not eliminate handset cyclicality. The ARM jury outcome does not settle appeals or remedies, so avoid pricing in a definitive competitive advantage from litigation headlines.

Key Decisions for Investors

• QCOM: Favor a staged long rather than chasing the initial reaction; add only as reported data-center shipments track the ramp and QCT operating leverage is visible. Reassess if shipments materially miss the company’s quarterly outlook, or if gross-margin pressure is not offset by the announced pricing actions in the second half of fiscal 2027.
• Watch the next 1–3 months for channel inventory and handset sell-through: evidence that Android growth is pre-buying ahead of price increases would weaken the diversification offset and argue against adding QCOM.
• Do not short ARM solely on the jury result. Treat appeals, remedies, and any effect on Qualcomm’s CPU licensing economics as event risks; a legal reversal or adverse remedy would challenge the relative thesis.
• LITE and GLW are watchlist beneficiaries, not yet supported by a standalone trade: seek customer/program disclosure or measurable optical revenue contribution before underwriting the connectivity opportunity.